Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.

Bhattacharya, Manojit; Sharma, Ashish R; Patra, Prasanta; Ghosh, Pratik; Sharma, Garima; Patra, Bidhan C; Lee, Sang-Soo; Chakraborty, Chiranjib
Journal of medical virology
2020Feb ; 570 ( 3 ) :.
ÀúÀÚ »ó¼¼Á¤º¸
Bhattacharya, Manojit -
Sharma, Ashish R -
Patra, Prasanta -
Ghosh, Pratik -
Sharma, Garima -
Patra, Bidhan C -
Lee, Sang-Soo -
Chakraborty, Chiranjib -
ABSTRACT
Recently, a novel coronavirus (SARS-COV-2) emerged which is responsible for the recent outbreak in Wuhan, China. Genetically, it is closely related to SARS-CoV and MERS-CoV. The situation is getting worse and worse, therefore, there is an urgent need for designing a suitable peptide vaccine component against the SARS-COV-2. Here, we characterized spike glycoprotein to obtain immunogenic epitopes. Next, we chose 13 Major Histocompatibility Complex-(MHC) I and 3 MHC-II epitopes, having antigenic properties. These epitopes are usually linked to specific linkers to build vaccine components and molecularly dock on toll-like receptor-5 to get binding affinity. Therefore, to provide a fast immunogenic profile of these epitopes, we performed immunoinformatics analysis so that the rapid development of the vaccine might bring this disastrous situation to the end earlier. CI - ??2020 Wiley Periodicals, Inc.
keyword
SARS-COV-2;epitopes;immunoinformatics;vaccine
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
This present immunoinformatic analysis pointed out 13 MHC‐I and 3 MHC‐II epitopes within the spike glycoprotein of SARS‐COV‐2.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå